Current Report Filing (8-k)
22 August 2014 - 4:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
August 21, 2014
Date of Report (Date of Earliest
Event Reported)
IntelGenx Technologies Corp.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
000-31187 |
870638336 |
(State or other jurisdiction of |
(Commission File |
(IRS Employer Identification |
incorporation) |
Number) |
No.) |
6425 Abrams, Ville St- Laurent, Quebec, Canada
|
H4S 1X9 |
(Address of principal executive offices) |
(Zip Code) |
Registrant's telephone number, including area code: (514)
331-7440
Check the appropriate box below if the Form 8K fining is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425
under the Securities Act (17CFR230.425)
[ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communication pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 Other Events - News Release
IntelGenx to Present at the Rodman & Renshaw Global
Investment Conference
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
INTELGENX TECHNOLOGIES CORP.
Dated: August 21, 2014 |
By: /s/ Paul A.
Simmons
|
|
Paul A.
Simmons |
|
Chief
Financial Officer |
Exhibit 99.1
IntelGenx to Present at the Rodman &
Renshaw Global Investment Conference
Saint Laurent, Quebec--(August 21, 2014) -
IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") today announced that Dr.
Horst Zerbe, Chairman, President and Chief Executive Officer, will present at
the Rodman & Renshaw Global Investment Conference to be held September 9, 2014
at 9:35am Eastern Time.
The Rodman & Renshaw Conference will
take place at The New York Palace hotel on September 8-10, 2014. To learn more
about the conference, please visit:
http://www.rodm.com
About IntelGenx:
IntelGenx is a drug delivery company
focused on the development of oral controlled-release products as well as novel
rapidly disintegrating delivery systems. IntelGenx uses its unique multiple
layer delivery system to provide zero-order release of active drugs in the
gastrointestinal tract. IntelGenx has also developed novel delivery technologies
for the rapid delivery of pharmaceutically active substances in the oral cavity
based on its experience with rapidly disintegrating films. IntelGenx'
development pipeline includes products for the treatment of indications such as
severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS
indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal
health products. More information is available about the company at
www.intelgenx.com.
Investor Contact:
COCKRELL GROUP
T: 877.889.1972
investorrelations@thecockrellgroup.com
cockrellgroup.com
Company Contact:
Paul A. Simmons
Chief Financial Officer
IntelGenx Technologies Corp.
T: +1 514-331-7440
F: +1 514-331-0436
intelgenx.com
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From Apr 2024 to May 2024
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From May 2023 to May 2024